Poster Abstract Session:
217. Antimicrobial Stewardship: Role of Diagnostics
Saturday, October 10, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

-

Tracks: Adult ID, Epidemiology and Infection Control, Pediatric ID

Presentations:
The Utility of "Culture if Spikes"
Katherine Linsenmeyer, MD ; Kalpana Gupta, MD, MPH ; Judith Strymish, MD ; Muhammad Dhanani, MD ; Anthony Breu, MD
Posters
  • Utility of Blood Cultures.pdf (461.4 kB)
  • Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle for Local Management of Gram-Negative Bloodstream Infections
    Elizabeth Nimmich, MD ; Thomas Smith III, MD ; Julie Ann Justo, PharmD, MS, BCPS, AAHIVP ; P. Brandon Bookstaver, PharmD, FCCP, BCPS (AQ-ID), AAHIVP ; Katie Hammer, PharmD ; Joseph Kohn, PharmD, BCPS ; Helmut Albrecht, MD ; Majdi Al-Hasan, MD
    Posters
  • IDWeek Poster 1485 Final.pdf (527.9 kB)
  • Antimicrobial Stewardship and the Use of Verigene® Gram-Positive and Gram-Negative Rapid Identification System
    Donna R. Burgess, RPh ; Sarah Tennant, PharmD ; Julie Ribes, MD, PhD ; David S. Burgess, PharmD, FCCP
    Posters
  • Nanosphere poster_FINAL.pdf (189.2 kB)
  • Antibiotic Prescribing Outcomes Before and After Implementation of a Rapid Diagnostic Assay Without the Concomitant Use of an Antimicrobial Stewardship Intervention
    William Greendyke, MD ; John Angiolillo, MD ; Christine J. Kubin, PharmD BCPS (AQ-ID) ; Susan Whittier, PhD ; E. Yoko Furuya, MD, MS
    Improved Clinical Outcomes after Implementation of Molecular Detection of Blood Culture Contaminants
    Erica Stohs, MD, MPH ; Michael a. Saubolle, PhD, FIDSA ; Cheryl O'malley, MD, FACP
    Posters
  • ID Week Poster 1491.pdf (4.8 MB)
  • Experience with Rapid Diagnostic Technology and Antimicrobial Stewardship for Patients with Gram-positive Bloodstream Infections
    Elizabeth Neuner, PharmD ; Andrea Pallotta, Pharm.D. ; Simon Lam, PharmD ; David Stowe, RPh ; Lisa Stempak, MD ; Gary Procop, MD, FIDSA ; Sandra S. Richter, MD, FIDSA
    Evaluation of time-to-positivity of clinically significant bacteremia
    Tina Dinh, Pharm.D. ; Elizabeth Zhu, PharmD, BCPS
    Effect of Inoculation Method on Anti-Staphylococcal Antibiotic Utilization and Clinical Outcomes in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia
    Jessica Frye, PharmD ; Dimple Patel, PharmD, BCPS-AQ ID ; Esther King, PharmD ; John Mcguire, MPA, BS, BT ; Joel Maslow, MD, PhD, MBA
    Posters
  • Frye_ID Week Poster.pdf (895.5 kB)
  • Effects of the Implementation of Reflexive Urine Cultures on Antibiotic Utilization in Hospitalized Patients
    Lindsay Petty, M.D. ; Jessica P. Ridgway, MD ; Natasha Pettit, PharmD ; Angella Charnot-Katsikas, MD ; Vera Tesic, MD, MS ; Kathleen G. Beavis, MD ; Jennifer M. Pisano, MD
    Posters
  • Slide1.jpg (116.5 kB)
  • Impact of Urine Testing on Unnecessary Antibiotic use for Asymptomatic Bacteriuria
    Corinne Klein, MD ; Miriam R. Elman, MPH ; Adam Brady, MBBChBAO ; James Lewis II, PharmD, FIDSA ; Erin Bonura, MD ; Jessina C. Mcgregor, PhD
    Posters
  • Poster rough draft4_jcm_mre.pdf (247.7 kB)
  • Influence of a “no MRSA, no Pseudomonas” Comment to a Respiratory Culture in Antibiotic Utilization During the Treatment of Lower Respiratory Tract Infection
    Joseph Mcbride, MD ; Lucas Schulz, PharmD ; Barry Fox, MD, FIDSA, FSHEA ; J Dipoto, PharmD ; Nathan Sippel, PharmD ; Kurt Osterby, BS
    Posters
  • IDweekFinal1.pdf (259.5 kB)
  • Impact of a Procalcitonin-based Treatment Guideline on Antibiotic Prescribing in Cardiology Patients with Suspected Respiratory Tract Infection
    Katie Wallace, PharmD ; Monty Yoder, PharmD ; James Beardsley, PharmD ; James Johnson, PharmD ; Vera Luther, MD ; Christopher Ohl, MD, FIDSA ; John Williamson, PharmD
    “Real World” Fungal Antigen testing: An Opportunity for Infectious Disease Physicians
    Michele Yamamoto, MD ; Iva Zivna, MD ; Elizabeth Radigan, PharmD ; Gail Scully, MD, MPH, FSHEA
    Use of Organism Identification by 16S Ribosomal RNA Polymerase Chain Reaction to Shorten Antimicrobial Length of Therapy
    Filiz Yucebay, PharmD ; Elise Gilbert, PharmD ; Danielle Smith, PharmD ; John Esterly, PharmD ; Chao Qi, PhD ; Michael Malczynski, BS ; Michael Postelnick, RPh ; Milena Mclaughlin, PharmD, MSc
    Use of a Combination Biomarker Algorithm to Identify Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection
    Jennifer Han, MD, MSCE ; Irving Nachamkin, DrPH, MPH, FIDSA ; Susan Coffin, MD, MPH, FPIDS ; Jeffrey S. Gerber, MD, PhD ; Barry Fuchs, MD ; Charles Garrigan, MB ; Xiaoyan Han, MS ; Warren Bilker, PhD ; Jacqueleen Wise, BA ; Pam Tolomeo, MPH ; Ebbing Lautenbach, MD, MPH, MSCE, FIDSA, FSHEA
    Posters
  • 1504_IDWeek.pdf (468.4 kB)
  • Use of a Combination Biomarker Algorithm to Identify Critically Ill Surgical Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection
    Jennifer Han, MD, MSCE ; Irving Nachamkin, DrPH, MPH, FIDSA ; Susan Coffin, MD, MPH, FPIDS ; Jeffrey S. Gerber, MD, PhD ; Charles Garrigan, MB ; Xiaoyan Han, MS ; Warren Bilker, PhD ; Jacqueleen Wise, BA ; Pam Tolomeo, MPH ; Ebbing Lautenbach, MD, MPH, MSCE, FIDSA, FSHEA
    The Impact of Negative Procalcitonin (PCT) Levels on Antimicrobial Usage in Patients with an Admitting Diagnosis of Pneumonia (PNA)
    Logan Vasina, PharmD, BCPS ; Joy Jiang, PharmD ; Christina Vu, BS ; Alexandra Perreiter, PharmD, MAS, BCPS ; Raymond Chinn, MD, FIDSA, FSHEA
    Posters
  • IDSA_Poster_PCTv9.png (1.1 MB)
  • Impact of Procalcitonin (PCT) Guidance on Antimicrobial Stewardship in a Community Hospital
    James Newton Jr., MD ; Cheryl Lim, MSc -Inf Dis ; Samantha Robinson, MS ; Kristi Kuper, PharmD ; Kevin W. Garey, PharmD, M.S. ; Kavita K. Trivedi, MD
    Discordant Effectiveness of Low Versus High Procalcitonin (PCT) Results on Antibiotic Administration in Hospitalized Patients
    Meghan Brennan, MD ; Kurt Osterby, BS ; Lucas Schulz, PharmD ; Alexander Lepak, MD
    Posters
  • AlexLepak Procalcitonin.pdf (133.2 kB)
  • CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.